Back to News
Market Impact: 0.25

SMCI Quantitative Stock Analysis

SMCIBRK.ABRK.BNDAQ
Company FundamentalsAnalyst InsightsTechnology & InnovationCorporate Earnings
SMCI Quantitative Stock Analysis

Validea's guru fundamental report indicates that Super Micro Computer Inc. (SMCI) receives a 59% rating based on their Warren Buffett-inspired "Patient Investor" model, which favors firms with predictable profitability, low debt, and reasonable valuations; while SMCI passes tests for earnings predictability, debt service, initial rate of return, and expected return, it fails in return on equity, return on total capital, and free cash flow, suggesting mixed alignment with Buffett's strategy.

Analysis

Super Micro Computer Inc. (SMCI), a large-cap growth stock in the Computer Hardware industry, receives a 59% rating from Validea's Patient Investor model, which is based on Warren Buffett's strategy emphasizing long-term, predictable profitability, low debt, and reasonable valuations. This score is below the 80% threshold typically indicating strategy interest and significantly below the 90% mark for strong interest, suggesting a moderate alignment at best. SMCI successfully meets criteria for Earnings Predictability, Debt Service, Use of Retained Earnings, Initial Rate of Return, and Expected Return. However, the company fails on critical metrics such as Return on Equity, Return on Total Capital, and Free Cash Flow, while its Share Repurchase activity is deemed neutral. This mixed performance highlights strengths in earnings consistency and debt management but significant weaknesses in capital efficiency and cash generation, contributing to a 'mixed' overall sentiment score of 0.1 for SMCI.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo

Market Sentiment

Overall Sentiment

mixed

Sentiment Score

0.10

Ticker Sentiment

BRK.A0.00
BRK.B0.00
NDAQ0.00
SMCI0.10

Key Decisions for Investors

  • Investors should note SMCI's moderate alignment with the Buffett-style 'Patient Investor' criteria, particularly the failures in Return on Equity, Return on Total Capital, and Free Cash Flow, which warrant further investigation.
  • Consider the passed tests for earnings predictability and low debt service as positive fundamental signals, but weigh them against the significant shortcomings in profitability returns and cash generation.
  • Given the mixed fundamental signals and a 59% score, a cautious approach is advised, potentially involving deeper due diligence into the reasons for subpar ROE, ROTC, and FCF before committing capital based on this specific value strategy.